晚期肺癌患者的以患者为中心的姑息治疗
本文综述了早期姑息治疗在晚期肺癌中的证据基础,指出专科姑息治疗可改善患者报告结局与临终关怀利用,并论述免疫检查点抑制剂与靶向治疗时代患者面临的新挑战,提出以患者为中心、量身定制及基于技术的姑息治疗干预是 promising 策略。
要点
- 早期引入专科姑息治疗可改善晚期肺癌患者的生活质量等患者报告结局与临终关怀利用。
- 免疫检查点抑制剂与靶向治疗改变患者体验与结局,带来新的副作用谱与预后不确定性。
- 量身定制及基于技术的姑息治疗干预是实施以患者为中心姑息治疗的 promising 策略。
核心结论
- 早期关注姑息治疗对包括晚期肺癌在内的严重肿瘤患者益处证据充分,专科姑息治疗早期参与可改善患者报告结局与医疗照护提供。
- 随着肺癌治疗格局改变,患者面临新的副作用谱与预后不确定性等挑战,姑息治疗临床医生可能需要学习新技能以支持接受新型治疗的患者。
- 量身定制及基于技术的姑息治疗干预是实施以患者为中心姑息治疗的 promising 策略。
研究设计与样本
- 本文为综述,梳理早期姑息治疗用于晚期肺癌患者的证据基础及其在新型治疗时代的演变。
主要发现
- 早期引入专科培训的姑息治疗临床医生可改善晚期肺癌患者的生活质量等患者报告结局,并改善临终关怀利用等医疗照护提供。
- 多数晚期肺癌患者目前接受免疫检查点抑制剂或靶向治疗,二者对患者体验与结局有显著影响。
- 生存更长的晚期肿瘤患者还面临性健康与运动等生存者问题及临终照护决策的困扰。
临床怎么用
- 专科姑息治疗临床医生仍适合处理上述照护需求,但原文指出其可能需要学习新技能以支持接受新型治疗的患者。
- 原文认为姑息治疗研究干预与临床项目也应以患者为中心的方式提供,以最好地满足患者需求并改善其结局。
- 原文提出量身定制及基于技术的姑息治疗干预是实施以患者为中心姑息治疗的 promising 策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The evidence base demonstrating the benefits of an early focus on palliative care for patients with serious cancers, including advanced lung cancer, is substantial. Early involvement of specialty-trained palliative care clinicians in the care of patients with advanced lung cancer improves patient-reported outcomes, such as quality of life, and health care delivery, including hospice utilization. Since the time that many of these palliative care trials were conducted, the paradigm of cancer care for many cancers, including lung cancer, has changed dramatically. The majority of patients with advanced lung cancer are now treated with immune checkpoint inhibitors or targeted therapies, both of which have had a significant impact on patient's experience and outcomes. With this changing landscape of lung cancer therapeutics, patients are facing new and different challenges, including dealing with novel side effect profiles and coping with greater uncertainty regarding their prognosis. Patients who are living longer with their advanced cancer also struggle with how to address survivorship issues, such as sexual health and exercise, and decision making about end-of-life care. Although palliative care clinicians remain well-suited to address these care needs, they may need to learn new skills to support patients treated with novel therapies. Additionally, as the experience of patients with advanced lung cancer is becoming more varied and individualized, palliative care research interventions and clinical programs should also be delivered in a patient-centered manner to best meet patient's needs and improve their outcomes. Tailored and technology-based palliative care interventions are promising strategies for delivering patient-centered palliative care.
引用
- Temel JS, Petrillo LA, Greer JA, et al. Patient-Centered Palliative Care for Patients With Advanced Lung Cancer. J Clin Oncol. 2022. PMID: 34985932. doi:10.1200/JCO.21.01710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。